SYSCHEM (INDIA)
Back to Balance Sheet
|
SYSCHEM (INDIA) Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹124 Cr | ₹97 Cr | ₹43 Cr | ₹26 Cr | ₹41 Cr |
What is the latest Total Current Liabilities ratio of SYSCHEM (INDIA) ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹124 Cr |
| Mar2024 | ₹97 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹26 Cr |
| Mar2021 | ₹41 Cr |
How is Total Current Liabilities of SYSCHEM (INDIA) Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹124 Cr | 28.19 | |
| Mar2024 | ₹97 Cr | 125.18 | |
| Mar2023 | ₹43 Cr | 68.27 | |
| Mar2022 | ₹26 Cr | -37.54 | |
| Mar2021 | ₹41 Cr | - | |
Compare Total Current Liabilities of peers of SYSCHEM (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYSCHEM (INDIA) | ₹189.0 Cr | 13.6% | -4.8% | -33.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
SYSCHEM (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYSCHEM (INDIA) | 13.6% |
-4.8% |
-33.4% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses